SCHEMBL8470458

SCHEMBL8470458

CCCn1c(=O)n(N2CCNC(c3ccc(Cc4ccccc4)cc3)C2)c2ccccc21

nearest known ligand 0.36

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ SLC6A2 P23975 3/20 0.36
▸ SLC6A4 P31645 2/20 0.36
▸ KDM4E B2RXH2 1/20 0.36
▸ ALDH1A1 P00352 1/20 0.36
▸ LMNA P02545 1/20 0.36
▸ POLB P06746 1/20 0.36
▸ HPGD P15428 1/20 0.36
▸ HSD17B10 Q99714 1/20 0.36
▸ PGR P06401 1/20 0.34
▸ DRD2 P14416 1/20 0.34
▸ DRD3 P35462 1/20 0.34
▸ SIGMAR1 Q99720 2/20 0.34
▸ TMEM97 Q5BJF2 1/20 0.34
▸ GSK3B P49841 2/20 0.32
▸ LTA4H P09960 1/20 0.32
▸ MEN1 O00255 1/20 0.32
▸ KMT2A Q03164 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8470455 0.76 SLC6A2 (0.43) SLC6A2SLC6A4PGRDRD2DRD3
SCHEMBL7085098 0.66 POLB (0.39) SLC6A2SLC6A4LMNAPOLBDRD2
SCHEMBL6909258 0.63 PGR (0.57) SLC6A2SLC6A4KDM4EALDH1A1PGR
SCHEMBL8407506 0.61 KDM4E (0.49) KDM4EALDH1A1LMNAPOLBHPGD
SCHEMBL4668715 0.61 CACNA1G (0.50) SLC6A2SLC6A4ALDH1A1LMNAPGR
SCHEMBL1829565 0.60 LTA4H (0.54) POLBLTA4H
SCHEMBL90572 0.60 PDE10A (0.45) SLC6A2SLC6A4KDM4EALDH1A1HSD17B10
SCHEMBL2910280 0.60 PDE10A (0.45) SLC6A2SLC6A4KDM4EALDH1A1HSD17B10
SCHEMBL2908444 0.60 PDE10A (0.45) SLC6A2SLC6A4KDM4EALDH1A1HSD17B10
SCHEMBL24665898 0.59 CYP1A2 (0.61) ALDH1A1LMNAPOLBPGRMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5889010-A PSYCHOLOGICAL DISORDERS; UROGENITAL DISORDERS; COGNITION ACTIVATORS; NERVOUS SYSTEM DISORDERS; VISION DEFECTS; CONGESTIVE HEART FAILURE; DRUG ABRUSE; PARKINSON'S DISEASE;ANTIINFLAMMATORY AGENTS; ANTIALLERGENS PFIZER INC. (US) 1999-03-30 — — US disclosed
US-5883094-A Benzimidazolone derivatives with central dopaminergic activity PFIZER INC. (US) 1999-03-16 — — US disclosed
Send feedback